Acadia Pharmaceuticals ACAD Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's operating income?
- Acadia Pharmaceuticals (ACAD) reported operating income of -$4.62M in Q1 2026.
- How has Acadia Pharmaceuticals's operating income changed year-over-year?
- Acadia Pharmaceuticals's operating income decreased by 123.9% year-over-year, from $19.29M to -$4.62M.
- What is the long-term trend for Acadia Pharmaceuticals's operating income?
- Over 3 years (2021 to 2025), Acadia Pharmaceuticals's operating income has grown at a -15.0% compound annual growth rate (CAGR), from -$170.44M to $104.81M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.